ClinicalTrialsFinder

Tumor Infiltrating Lymphocyte Clinical Trials in Shanghai, None Selected

1 recruitingShanghai, None Selected, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer

Colorectal Cancer (CRC)PD-1Tumor Infiltrating Lymphocytes
Ruijin Hospital29 enrolled1 locationNCT07035002